<DOC>
	<DOCNO>NCT01885871</DOCNO>
	<brief_summary>The purpose study determine whether picosecond laser effective treatment age ( sun ) spot .</brief_summary>
	<brief_title>Laser Removal Age ( Sun ) Spots Hands</brief_title>
	<detailed_description>The purpose study evaluate safety efficacy Cutera Picosecond Q-Switched Nd : YAG 1064 and/or 532 nm laser treatment benign pigment lesion hand .</detailed_description>
	<mesh_term>Lentigo</mesh_term>
	<criteria>Females Males , 18 60 year age ( inclusive ) . Fitzpatrick Skin Type I III ( Appendix 2 ) . Clinical diagnosis benign solar lentigo hand . Presence least 5 lesion treatment area diameter range 1 8 mm . Has use prescription counter topical cream ( e.g. , hydroquinone , and/or retinoids and/or corticosteroid ) use treatment pigmentation treatment area within last 4 week . Willing refrain use prescription counter topical cream use treatment pigmentation ( e.g. , hydroquinone , and/or retinoids and/or corticosteroid ) treatment area study period . Must able read , understand sign Informed Consent Form . Willing able adhere treatment followup schedule treatment care instruction . Willing protect and/or limit sun exposure use approve sunscreen SPF 50 high treatment area start 4 week treatment , every day duration study , include followup period Willing digital photograph take treatment area Agree undergo procedure ( ) treatment solar lentigo study . Postmenopausal surgically sterilize , use medically acceptable form birth control last 3 month prior enrollment entire course study . Participation study another device drug within 6 month prior enrollment study . Prior treatment solar lentigo hand , e.g. , QSwitched laser , IPL , Chemical peel , cryotherapy within 6 month study participation . Having premalignant malignant lesion ( e.g. , pigment actinic keratosis , lentigo maligna [ 12 ] , lentigo maligna melanoma ) , history premalignant malignant lesion treatment area . Subject show sign actinic bronze recent tan treatment area , unable/unlikely refrain tan study . Skin abnormalities treatment area , e.g. , cut , scrape , wound , scar , large mole . Pregnant and/or breastfeeding . Having infection , dermatitis rash treatment area . Significant concurrent illness , diabetes mellitus cardiovascular disease , e.g. , uncontrolled hypertension Suffering coagulation disorder take prescription anticoagulation medication . History keloid scarring , hypertrophic scar abnormal wound healing . History immunosuppression/immune deficiency disorder currently use immunosuppression medication . History vitiligo psoriasis . History connective tissue disease , systemic lupus erythematosus scleroderma . History seizure disorder due light . Any use medication know increase sensitivity light , tetracycline . History radiation treatment area undergo systemic chemotherapy treatment cancer . History pigmentary disorder , particularly tendency hyper hypopigmentation . Anytime life , use gold therapy ( gold salt ) disorder rheumatologic disease lupus . Current smoker history smoking within 2 year study participation . As per Investigator 's discretion , physical mental condition might make unsafe subject participate study . History allergy topical antibiotic .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Sun</keyword>
	<keyword>Age</keyword>
	<keyword>Spot</keyword>
</DOC>